TGFBI and nonpapillary renal cell carcinoma: Based on integrative analyses of transcriptomic landscape and urinary signature, the urine-based prognostic classifier consisting of VSIG4, TGFBI, and P4HB has satisfied predictive power of survival time, pathological grade and stage in ccRCC patients, which facilitate ccRCC molecular subtyping and treatment.